Driven by strong R&D as well as manufacturing capability, we believe in accelerating drug development for the world. We offer a state-of-the art platform for the development of biosimilars, biotherapeutics and mRNA Vaccines using E.coli as host system.
With strong research capabilities at our core, and world class manufacturing facilities at our disposal, we are involved in cutting edge innovation and production of linear mRNA and self amplifying mRNA used in vaccine development as well as mRNA therapeutics.
Our mission is to develop into an integrated biotechnology company that transforms its R&D endeavours into cost effective healthcare products of highest quality to serve the economically challenged patients across the world.We aim to become a leader in developing and manufacturing of niche therapeutic bio-similars in the market segments such as Oncology, Diabetics & Osteoporosis products while creating value for all stakeholders.
